J&J seeks cardiovascular market growth with $13.1bn Shockwave deal
The deal expands J&J's footprint in coronary artery disease and peripheral artery disease treatment devices.
08 April 2024
08 April 2024
The deal expands J&J's footprint in coronary artery disease and peripheral artery disease treatment devices.
The acquisition will give the Japanese medtech firm a greater foothold in the European market taking over an app already present in 70% of Dutch hospitals.
The SOFT PLUG Extended Duration 180-T Tapered Plug features a 0.25mm tapered end.
The Neuraceq imaging agent for beta-amyloid PET scans will be distributed from SOFIE's site in Cleveland, Ohio.
The BD FACSDiscover S8 Cell Sorters are designed to offer real-time imaging and spectral flow cytometry capabilities.
Xenotransplantation is said to be "on the brink of a monumental breakthrough" following the successful operation.
The companies are also preparing for a FDA submission for the AI-guided ultrasound system.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.